Genesee Scientific Inc. Laboratories manufactures the genclone company serum reagents distributed by Genprice. The Genclone Company Serum reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Genesee Scientific Inc.. Other Genclone products are available in stock. Specificity: Genclone Category: Company Group: Serum
Serum information
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|
SER71209-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 12 months post immunisation |
Yellow Fever Virus Vaccine Serum: 2 Week (IgM) Bleed |
|
SER71201-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 2 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 2 Week (IgM) Bleed |
|
SER71201-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 2 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|
SER71202-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|
SER71202-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 weeks post immunisation. |
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|
SER71210-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of the Japanese Encephalitis Virus vaccine (IXIARO (Strain SA14)), 6 months post immunisation. |
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|
SER71210-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of the Japanese Encephalitis Virus vaccine (IXIARO (Strain SA14)), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71200-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71200-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|
SER71206-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|
SER71206-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation. |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71207-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71207-500 |
The Native Antigen Company |
0.5ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Yellow Fever Virus Vaccine Serum: Vaccination Time-Course Panel |
|
SER71205-1000 |
The Native Antigen Company |
3x1ml |
EUR 1538.64 |
|
Description: Triple pack of samples from an individual who was immunised with theYellow Fever vaccine Stamaril (17D strain). The first vial is a pre-bleed sample, taken one week before the immunisation. The second vial is an “IgM” vial, taken 2 weeks post immunisation. The third vial is an “IgG” vial taken 6weeks post immunisation. |